Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

A new approach to stroke management.

J Rothrock¹, B J Taft, P D Lyden

¹University of California, San Diego.

American Family Physician

|October 1, 1987

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Ultra-rapid identification, triage, and enrollment of stroke patients into clinical trials.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2015

Same author

Protease activated receptor-1 mediates cytotoxicity during ischemia using in vivo and in vitro models.

Neuroscience·2014

Same author

Anti-adrenergic medications and edema development after intracerebral hemorrhage.

Neurocritical care·2011

Same author

Production and validation of Putonghua- and Cantonese-Chinese language National Institutes of Health Stroke Scale training and certification videos.

International journal of stroke : official journal of the International Stroke Society·2010

Same author

The modified National Institutes of Health Stroke Scale: its time has come.

International journal of stroke : official journal of the International Stroke Society·2009

Same author

Prior antiplatelet use does not affect hemorrhage growth or outcome after ICH.

Neurology·2009

Same journal

For Post-stent Patients With Atherosclerotic Coronary Vascular Disease Who Are Taking an Anticoagulant, Adding Aspirin Worsens Outcomes.

American family physician·2026

Same journal

Nausea and Vomiting During Pregnancy.

American family physician·2026

Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease: Diagnosis and Management.

American family physician·2026

Same journal

Aerobic Exercise Is the Better Exercise Modality for Knee Osteoarthritis.

American family physician·2026

Same journal

Overscreening Leads to Overdiagnosis of MASLD.

American family physician·2026

Same journal

Type 2 Diabetes: Outpatient Insulin Management.

American family physician·2026

See all related articles

Stroke incidence is decreasing due to risk factor management, not specific therapies. Future stroke care should prioritize acute intervention and cerebral resuscitation.

Area of Science:

Neurology
Vascular Medicine
Public Health

Background:

Stroke incidence has declined in recent decades.
This decline is primarily attributed to effective management of cardiovascular risk factors.
Stroke-specific therapies have not significantly contributed to this trend.

Observation:

Current diagnostic techniques for stroke and transient ischemic attack (TIA) have improved.
Aggressive management of TIA and asymptomatic carotid artery disease is costly.
The clinical benefit of aggressive management for TIA and asymptomatic carotid disease is questionable.

Findings:

The effectiveness of current stroke prevention strategies is primarily linked to risk factor control.
Advanced diagnostics have not translated into equally effective stroke-specific treatments.

Related Experiment Videos

The value of intensive interventions for certain conditions like TIA and asymptomatic carotid disease is uncertain.

Implications:

The clinical focus for stroke management should transition from prevention to acute treatment.
There is a need to prioritize "cerebral resuscitation" strategies for acute stroke.
Future research and clinical practice should emphasize rapid intervention to improve stroke outcomes.